Does ENTECAVIR Cause Hepatocellular carcinoma? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Hepatocellular carcinoma have been filed in association with ENTECAVIR (Entecavir). This represents 2.1% of all adverse event reports for ENTECAVIR.
94
Reports of Hepatocellular carcinoma with ENTECAVIR
2.1%
of all ENTECAVIR reports
41
Deaths
40
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From ENTECAVIR?
Of the 94 reports, 41 (43.6%) resulted in death, 40 (42.6%) required hospitalization, and 4 (4.3%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
Yes, Hepatocellular carcinoma is listed as a known adverse reaction in the official FDA drug label for ENTECAVIR.
What Other Side Effects Does ENTECAVIR Cause?
Drug resistance (312)
Death (298)
Drug ineffective (207)
Hepatitis b (166)
Off label use (129)
Maternal exposure during pregnancy (126)
Viral mutation identified (121)
Renal impairment (118)
Pathogen resistance (115)
Fatigue (108)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which ENTECAVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
ENTECAVIR vs ENTINOSTAT
ENTECAVIR vs ENTRECTINIB
ENTECAVIR vs ENZALUTAMIDE
ENTECAVIR vs EPCORITAMAB
ENTECAVIR vs EPCORITAMAB-BYSP